Clinical trials
COVID-19 trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 17 |
| 2021 | 14 |
| 2022 | 6 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 12 |
| Unknown status | 7 |
| Recruiting | 4 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atea Pharmaceuticals, Inc. | 2 |
| Gilead Sciences | 2 |
| Grigore T. Popa University of Medicine and Pharmacy | 2 |
| Hoffmann-La Roche | 2 |
| Invivyd, Inc. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Professor Adrian Covic | 2 |
| Regeneron Pharmaceuticals | 2 |
| UMC Utrecht | 2 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 41 |
| Coronavirus Infections | 5 |
| Pneumonia | 4 |
| Influenza, Human | 3 |
| Anxiety Disorders | 2 |
| Community-Acquired Pneumonia | 2 |
| Lung Diseases | 2 |
| Lung Diseases, Interstitial | 2 |
| Post-Acute COVID-19 Syndrome | 2 |
| Respiratory Distress Syndrome | 2 |
Trials
Showing 26 to 41 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.